Translational Research Primer: Understanding Hypertension Through - - PowerPoint PPT Presentation

translational research primer
SMART_READER_LITE
LIVE PREVIEW

Translational Research Primer: Understanding Hypertension Through - - PowerPoint PPT Presentation

Translational Research Primer: Understanding Hypertension Through Animal &Human Investigation Scott Alan Smith, PhD Translation * Translational Research An effort to build on basic scientific research to create new therapies, medical


slide-1
SLIDE 1

Translational Research Primer:

Understanding Hypertension Through Animal &Human Investigation

Scott Alan Smith, PhD

Translation

slide-2
SLIDE 2

*

slide-3
SLIDE 3

Translational Research

  • An effort to build on basic scientific research to create

new therapies, medical procedures & diagnostics.

  • It is the “translation” of basic scientific findings in a

laboratory setting into potential treatments for disease.

slide-4
SLIDE 4

Translational Research

  • Step 1: Identify a significant problem
  • Step 2: Design and perform basic experiments

(pre-clinical studies)

  • Step 3: Design and perform clinical experiments
  • Step 4: Identify novel targets and/or methods for

treatment

slide-5
SLIDE 5

Advantages of Using Animal Models

  • Increased control of experimental conditions
  • Enhanced isolation of system or process of interest
  • Mechanistic studies at the cellular & molecular level available
  • Disease models readily available and/or inducible
  • Genetic manipulation of models available in some species
slide-6
SLIDE 6

Camilla Martin Christian Eriksen Eskild Ebbesen Thomas Bjorn

slide-7
SLIDE 7

exampleS

Caroline Wozniacki

slide-8
SLIDE 8
  • Disease characterized by chronic high blood pressure
  • In US, 32% of national population aged 20 or older has

hypertension

  • Major risk factor for development of heart disease,

peripheral arterial disease, stroke, heart failure, etc.

  • Accounts for 13.5% of all deaths
  • Estimated that 1.5 billion people will suffer from

hypertension by 2025 (1/3 of world’s population)

Hypertension

slide-9
SLIDE 9

Significant National & Global Health Problem

Additional and/or improved strategies are urgently needed to prevent and treat hypertension

slide-10
SLIDE 10
  • Medications
  • Diet (low salt)
  • Exercise
  • Bioelectronic Devices

Current Strategies to Treat Hypertension

Hold op

slide-11
SLIDE 11

Exercise is Medicine Example

slide-12
SLIDE 12
  • Heightens muscle endurance & metabolic efficiency
  • Enhances heart function
  • Improves glucose handling & insulin sensitivity
  • Reduces body weight & fat deposition
  • Decreases resting blood pressure

Why Exercise?

slide-13
SLIDE 13

Advarsel!!! Warning!!!

slide-14
SLIDE 14

The Pressor Response to Static Exercise is Exaggerated in Hypertensive Patients 20 40 60 80 100

D SBP D DBP

Isometric Handgrip (30% MVC)

NT (119/79) HT (162/112)

* *

Kazatani et al. Am J Ther 2: 165-169, 1995

mm Hg

slide-15
SLIDE 15

From Smith SA, Mitchell JH & Garry MG. Exp Physiol, 91: 89-102, 2006

Why?

slide-16
SLIDE 16

The Exercise Pressor Reflex is Overactive in Hypertension

Smith et al. J Physiol 577: 1009-1020, 2006

WKY: MAP = 89±8 mm Hg SHR: MAP = 149±5 mm Hg

Mizuno et al. Am J Physiol 300: H968-H977, 2011

D MAP (mm Hg) 20 40 60 D HR (beats min-1) 5 10 15 20

* *

D Tension (kg) 0.0 0.5 1.0 1.5 2.0 WKY SHR

WKY SHR

slide-17
SLIDE 17

SHR

X

Mizuno et al. Am J Physiol 300: H968-H977, 2011 Mizuno et al. J Physiol 589: 6191-6204, 2011

Effects of Blocking Skeletal Muscle Sensory Transmission in Hypertensive Rats

slide-18
SLIDE 18

Translation

slide-19
SLIDE 19

Intrathecal Fentanyl Infusion

slide-20
SLIDE 20

Time (min) ∆ Mean blood pressure (mmHg)

*P < 0.05 HT CTRL vs. NT †P < 0.05 HT CTRL vs. HT FENT

HT CTRL HT FENT NT

*† *† *† *† *†

slide-21
SLIDE 21

Treatment Targets

Reflex sensory traffic from skeletal muscle

  • Reduce risk of dangerous cardiovascular event during exercise
  • Allow exercise of increased intensity & duration
  • Enhance benefits of exercise training in hypertension
slide-22
SLIDE 22

Dietary Interventions Example

slide-23
SLIDE 23

Potential Target: Dietary Phosphate (Pi)

  • Inorganic phosphates (Pi) used as preservatives, flavor enhancers and color stabilizers
  • Pi additives present in 44% of top selling grocery items
  • Examples - prepared frozen foods, packaged meats, bread & baked goods, soups, sodas
  • Estimates suggest US adults consume approximately twice the recommended daily allowance

Phosphate Consumption BP?

slide-24
SLIDE 24

Collaborative Research Team

Pre-Clinical Studies Clinical Studies

Physiologist

  • W. Vonpatanasin, MD
  • S. Smith, PHD

Physiologist

  • M. Mizuno, PhD
  • L. Sandon, PhD, RD, LD

Cardiologist Dietician

Translational Research

slide-25
SLIDE 25

Pre-Clinical Studies

slide-26
SLIDE 26

Pre-Clinical Study Design

Normal Phosphate Diet (0.6% Pi) High Phosphate Diet (1.2% Pi) Males & Females 3 Months

Baseline MAP (mmHg) Normal Pi = 93±4 High Pi = 120±5

slide-27
SLIDE 27

Responses to Exercise Pressor Reflex Activation

From Mizuno et al. Am J Physiol, 311: R39-R48, 2016

0.6% Pi 1.2% Pi

slide-28
SLIDE 28

Translation

slide-29
SLIDE 29

Study Population

  • Subjects with Prehypertension (BP 120-139/80-89 mmHg)
  • 50% female
  • 50% African Americans
slide-30
SLIDE 30

Clinical Studies: Randomized Cross-over Design

Low Pi diet (700 mg/d) High Pi diet (1,200 mg/d) 4 wks Low Pi diet (700 mg/d) High Pi diet (1,200 mg/d) 4 wks Run-in Phase 2 wks

Washout phase 2 wks

slide-31
SLIDE 31

muscle SNA

Hand Grip 30% MVC

Effects of High Pi on Neural control of BP

SNA at rest and during handgrip. Measure after 4 weeks of high vs. low Pi diet.

slide-32
SLIDE 32

MSNA during Exercise

24 Hour Urine Phosphate = 818 mg 24 Hour Urine Phosphate = 1102 mg

slide-33
SLIDE 33

High-Phosphate Diet Induces Exercise Intolerance and Impairs Fatty Acid Metabolism

  • High Pi consumption decreases treadmill exercise time and spontaneous

activity level in mice

  • High Pi consumption downregulates key genes involved in fatty acid
  • xidation in mice
  • In humans, higher serum phosphate levels are associated with decreased

physical activity

  • P. Peri-Okonny et al. Circulation 139: 1422-1434, 2019
slide-34
SLIDE 34

Treatment Target

Phosphate consumption

  • Dietary phosphate consumption may prove a novel cardiovascular

risk factor that can be easily modified for the prevention or treatment of hypertension.

slide-35
SLIDE 35

Bioelectronic Devices Example

slide-36
SLIDE 36

Schlaich et al. J Am Coll Cardiol 62: 2031-2045, 2013

SNA SNA SNA SNA SNA

Response to Renal Injury/Ischemia:

Evidence from Animals and Humans

slide-37
SLIDE 37

Translation

slide-38
SLIDE 38

Schlaich et al. J Am Coll Cardiol 62: 2031-2045, 2013

slide-39
SLIDE 39

Symplicity HTN-1 Investigators, Hypertension 57: 911-917, 2011

slide-40
SLIDE 40

Treatment Target

Efferent and Afferent Renal Nerves

  • Catheter-based renal nerve ablation has been shown to

significantly lower systolic and diastolic blood pressure and may prove a viable long-term treatment for hypertension.

slide-41
SLIDE 41

Take Home Message

Translational research is the KEY to the practical application of basic science discoveries to the development and implementation of new ways to prevent, diagnose and treat disease.

2-Time Olympian 1968 Olympics (Mexico City) – 8th Single Sculls 1972 Olympics (Munich) – 4th Double Sculls World Champion 1970 – World Champion, World Rowing Championships

slide-42
SLIDE 42

Thank you!!!

Lars Ulrich

slide-43
SLIDE 43